MOPEAD newsletter 01

World Alzheimer's Day and the MOPEAD Project

Saturday 21st September marks World Alzheimer Day 2019, an important international event which aims to raise awareness about dementia. Over the whole month of September, Alzheimer’s Disease International (ADI) launched a global campaign under the theme of "Let's Talk About Dementia", and the MOPEAD team have been working to support this message by promoting timely diagnosis and the importance of memory health. ADI will also launch on World Alzheimer Day this year's World Alzheimer Report whihc draws on the results of a survey conducted by ADI and the London School of Economics (LSE) whihc focuses on attitudes towards dementia. This is the largest survey ever undertaken on the subject, with n

Interim Analysis of MOPEAD Project presented at AAIC 2019

Cambridge Cognition (CANTAB) presented an interim analysis of the MOPEAD Projects innovative citizen science patient engagement model at the Alzheimer’s Association International Conference (AAIC) 2019, Los Angles USA. This conference is the largest and most influential meeting dedicated to advancing dementia science, with an estimated 6,000 attendees this year alone. You can view the poster here. The Citizen Science Model The analysis was presented as a poster which highlighted the method and preliminary results and conclusions of the citizen science model. Developed by the MOPEAD team, this model (sometimes referred to as Run 1) invited members of the general public in five different Europ

MOPEAD launches World Alzheimer's Month campaign!

MOPEAD has begun it's campaign in support of World Alzheimer's Month 2019 which will take place over the month of September. This international campaign of Alzheimer’s Disease International (ADI) takes place every September to raise awareness and challenge the stigma that surrounds dementia. This year the theme of the campaign is "Let's Talk About Dementia" which MOPEAD will be supporting of it's main communication channels over the month. You can follow our campaign on: Twitter: @MopeadEU YouTube: Facebook: MOPEAD

©2019 MOPEAD

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under Grant Agreement No 115985. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations